Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Passage BIO, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −5 vs. Q1 2026
- Shares held
- 1.40M
- −381.9K (−21.5%) vs. Q1 2026
- Total value
- $6.82M
- −$7.01M (−50.7%) vs. Q1 2026
- New holders
- 4
- 5 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TSFG, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 3 | $15 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $59 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 12 | $59 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 15 | $73 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $73 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 115 | $561 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 169 | $825 | 0.00% | +45+36.3% | Added |
| Barclays PLC | 212 | $1.03K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 638 | $3.11K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,389 | $11.7K | 0.00% | −261−9.8% | Reduced |
| GTS Securities LLC | 10,000 | $48.8K | 0.00% | +10,000 | New |
| Fiduciary Trust Co | 10,750 | $52.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 12,712 | $62.0K | 0.00% | +12,712 | New |
| UBS Group AG | 13,565 | $66.2K | 0.00% | −13,936−50.7% | Reduced |
| Deltec Asset Management LLC | 15,000 | $73.2K | 0.01% | +15,000 | New |
| Vanguard Fiduciary Trust Co | 17,049 | $83.2K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 22,496 | $109.0K | 0.00% | −1,700−7.0% | Reduced |
| BlackRock, Inc. | 27,910 | $136.2K | 0.00% | −685−2.4% | Reduced |
| Boothbay Fund Management, LLC | 28,439 | $138.8K | 0.00% | +9,568+50.7% | Added |
| Verdad Advisers, LP | 30,728 | $150.0K | 0.14% | +8,600+38.9% | Added |
| Geode Capital Management, LLC | 37,026 | $180.7K | 0.00% | −4,354−10.5% | Reduced |
| Erste Asset Management GmbH | 40,665 | $197.2K | 0.00% | −44,597−52.3% | Reduced |
| Renaissance Technologies LLC | 47,892 | $233.7K | 0.00% | −85,720−64.2% | Reduced |
| Yiheng Capital Management, L.P. | 86,097 | $420.2K | 0.18% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 99,517 | $485.6K | 0.08% | +31,393+46.1% | Added |
| Balyasny Asset Management LLC | 107,025 | $522.3K | 0.00% | +107,025 | New |
| Vanguard Capital Management LLC | 113,964 | $556.1K | 0.00% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 673,759 | $3.29M | 0.38% | +50,055+8.0% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −305,000−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −131,581−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −19,530−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,627−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −4,955−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −502−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |